Serek-DP
Diclofenac Potassium 50 mg + Serratiopeptidase 15 mg + Paracetamol 325 mg
Clinical Differentiators & Advantages
PCD Franchise Distribution
Verify if exclusive marketing and distribution rights for Serek-DP are currently vacant in your target district.
Active Chemical Compounds & Molecular Architecture
Validated chemical entities, 2D skeletal bond diagrams, empirical molecular formulas, and receptor-level modes of action
Rapid-acting NSAID for swift control of acute joint and tissue inflammation.
Enhanced-dose enzyme improving drug penetration and micro-circulatory drainage.
Central analgesic and antipyretic providing synergistic pain relief.
Approved Clinical Indications & Disease Burden
Pharmacodynamic Mechanism of Action
Extra-strength triple-action formula: Diclofenac Potassium relieves peripheral inflammation; Paracetamol acts centrally to amplify pain thresholds; High-dose Serratiopeptidase accelerates drug penetration into joint capsules and clears swelling.
Dosage & Administration Protocol
1 tablet twice daily after meals.
Precautions, Warnings & Contraindications
B2B Commercial & Shipping Metrics
Moisture-sealed 5-ply export corrugation
Includes visual aids & promotional inputs
Private label & institutional supply
Standard pharmaceutical commercial tariff
Certificate of Analysis (COA), Stability Study Reports (Zone IVb), Finished Product Specs (FPS), and Material Safety Data Sheet (MSDS).
Frequently Prescribed & Stocked Together
Clinically aligned formulations commonly co-prescribed with Serek-DP to improve patient outcomes and expand distributor portfolio basket size.
APAR / APAR-S / APAR-MR Range
Aceclofenac + Paracetamol (± Serratiopeptidase / Thiocolchicoside)
“Super Speed, Super Power & Prompt Relief — Powerful Yet Safer”
CT-Flam
Trypsin 48 mg + Bromelain 90 mg + Rutoside Trihydrate 100 mg + Aceclofenac 100 mg
“Reduce Oedema with CT-Flam — Cut Down Suffering Softly”
Serek-D
Diclofenac Potassium 50 mg + Serratiopeptidase 10 mg
“Dual Action Rapid Pain Relief & Enzyme Penetration”